Search
Piperidione
go.drugbank.com/drugs/DB13224ExperimentalPiperidione was cough medicine marketed by Roche under the trade name Sedulon.
Nedocromil
go.drugbank.com/drugs/DB00716ApprovedA pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.
EP-1043
go.drugbank.com/drugs/DB06118ExperimentalThe vaccine consists of a string of 18 HIV-derived major histocompatibility complex (MHC) Class II restricted epitopes, each separated by a spacer designed to optimize potency. … The vaccine protein is adsorbed to Alhydrogel adjuvant and has been shown to effectively stimulate HTL responses against multiple epitopes in a mouse model.
Stavudine
go.drugbank.com/drugs/DB00649ApprovedInvestigationalA dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Lipoic acid
go.drugbank.com/drugs/DB00166ApprovedInvestigationalNutraceuticalA vitamin-like antioxidant.
Mixtures: Folic-K, Protect Plus SO 60Maropitant
go.drugbank.com/drugs/DB11427ExperimentalVet approvedIt was approved by the FDA in 2007 for use in dogs, and more recently has also been approved for use in cats. … Maropitant, used as maropitant citrate, is a neurokinin receptor antagonist, which was developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs.
3-amino-5-phenylpentane
go.drugbank.com/drugs/DB02869ExperimentalThese are compounds containing a phenylpropylamine moiety, which consists of a phenyl group substituted at the third carbon by a propan-1-amine. 3-amino-5-phenylpentane targets the proteins cathepsin K … This compound belongs to the phenylpropylamines.
Rosin
go.drugbank.com/drugs/DB11165ApprovedRosin has shown to mediate antibacterial actions on Gram-positive bacterial species [A27267]. … It is prepared from heating fresh liquid resin to vaporize the volatile liquid terpene components.
Methoxyphenamine
go.drugbank.com/drugs/DB13624ApprovedCategories: Non-selective Beta-adrenergic Agonists, Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeBioymifi
go.drugbank.com/drugs/DB17493ExperimentalUpon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.